Search
for
Sort by
Research 241–270 of 1000+
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
- A randomized, blinded, three-arm, multicenter trial comparing the efficacy and safety of fluconazole given once daily for 3 or 6 weeks with griseofulvin given once daily for 6 weeks in pediatric patients with tinea capitis
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
- Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
- Hypertrichosis in females applying minoxidil topical solution and in normal controls
- Cyclosporine-induced folliculodystrophy
- A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Minoxidil for patchy alopecia areata: systematic review and meta‐analysis
- Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
- Comment on “Low dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series”: Adding further evidence about side effects
- Factors predicting response to oral methylprednisolone tapering treatment in alopecia areata: A retrospective study
- Finasteride Use: Evaluation of Depression and Suicide Risk
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Systemic treatments for alopecia areata: A systematic review
- Topical Eflornithine
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- 660 Complex cellular flows shape feather follicle topology
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Sun protection policies and behaviors among U.S. child care centers
- Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Sunscreen: Cosmetic or medical therapy?
- Side effects of low-dose oral minoxidil for treating alopecia
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Repigmentation of Leukotrichia Due to Retrograde Migration of Melanocytes After Noncultured Epidermal Suspension Transplantation